(Q31817171)

4 July 2017

title

Nitric oxide synthase activity in peripheral polymorphonuclear leukocytes in patients with chronic congestive heart failure (English)

1 reference

4 July 2017

main subject

congestive heart failure

1 reference

1 reference

Mitsuke Y

1

1 reference

4 July 2017

Lee JD

2

1 reference

4 July 2017

Shimizu H

3

1 reference

4 July 2017

Uzui H

4

1 reference

4 July 2017

Iwasaki H

5

1 reference

4 July 2017

Ueda T

6

1 reference

4 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

American Journal of Cardiology

4 July 2017

published in

1 reference

4 July 2017

volume

87

1 reference

4 July 2017

issue

2

1 reference

4 July 2017

page(s)

183-187

1 reference

The L-arginine-nitric oxide pathway

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901313-8

Nitric oxide synthases: Roles, tolls, and controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901313-8

Nitric oxide synthase activities in human myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901313-8

Expression of inducible nitric oxide synthase in human heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901313-8

Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure: their relation to lesion site and beta-adrenergic receptor therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901313-8

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901313-8

Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901313-8

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901313-8

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901313-8

Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901313-8

Co-purification of 130 KD nitric oxide synthase and A 22 KD link protein from human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901313-8

Alterations in nitric oxide synthase activity, superoxide anion generation, and platelet aggregation in systemic hypertension, and effects of celiprolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901313-8

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901313-8

Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901313-8

Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901313-8

NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901313-8

Negative inotropic effects of cytokines on the heart mediated by nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901313-8

Beta-adrenergic regulation of constitutive nitric oxide synthase in cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901313-8

Natriuretic peptides modulate nitric oxide synthesis in cytokine-stimulated cardiac myocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901313-8

Norepinephrine suppresses inducible nitric oxide synthase activity in rat astroglial cultures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901313-8

Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901313-8

Nitric oxide synthase activity is increased in relation to the severity of liver dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901313-8

10.1016/S0002-9149(00)01313-8

7 January 2021

Identifiers

DOI

1 reference

4 July 2017

1 reference